Last reviewed · How we verify

NCT05374174

Validation of a Spasticity Measurement Tool

Active, enrolled Last updated 20 March 2026
What this trial tests

trial testing Tardieu Scale for Spasticity in Stroke in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
28 April 2022
Primary endpoint
1 February 2026
1 February 2027

Quick facts

Lead sponsorShirley Ryan AbilityLab
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment40
Start date28 April 2022
Primary completion1 February 2026
Estimated completion1 February 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Shirley Ryan AbilityLab — full company profile →

Who can join

Adults 18 to 75, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this project is to investigate the validity of a handheld spasticity measurement tool against standard clinical measurements of spasticity. We propose the testing apparatus will accurately provide an equivalent clinical measure of spasticity while also providing a more precise estimation of spastic response in persons with stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Shirley Ryan AbilityLab trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05374174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing